Novartis’ discovery team hires Genentech vet Shiva Malek to lead early-stage oncology work

A longtime discovery researcher at Genentech has jumped ship to run Novartis’ early-stage oncology work.

Jay Bradner

Shiva Malek, who had worked at the Roche-owned company for the last 15 years, is now in charge of the Novartis Institutes for BioMedical Research’s oncology department, a...

Click to view original post